Lasa Supergenerics (NSE:LASA) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


NSE:LASA Lasa Supergenerics Ltd NSE:LASA
46 GF Score
Price ₹7.60
GF Value ₹4.36
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Research & Development?

Lasa Supergenerics NSE:LASA -0.78% 46 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:LASA with a GF Score™ of 46/100 and a GF Value™ of ₹4.36 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Lasa Supergenerics's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Lasa Supergenerics  (NSE:LASA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lasa Supergenerics Research & Development Related Terms

Lasa Supergenerics Research & Development Historical Data

* Premium members only.

The historical data trend for Lasa Supergenerics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics Research & Development Chart

Lasa Supergenerics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lasa Supergenerics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:LASA
46GF Score
Lasa Supergenerics Ltd NSE:LASA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lasa Supergenerics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Lasa Supergenerics (NSE:LASA) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Lasa Supergenerics and its competitors.
Is Lasa Supergenerics' Research & Development too high?
Lasa Supergenerics' current Research & Development is ₹0.0 Mil. Overall, Lasa Supergenerics has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lasa Supergenerics' Research & Development compare to ZTS?
Lasa Supergenerics' Research & Development of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lasa Supergenerics and its competitors. Lasa Supergenerics's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lasa Supergenerics stock overvalued right now?
Based on GuruFocus' analysis, Lasa Supergenerics (NSE:LASA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹4.36, compared to a current price of ₹7.60 — trading 74.3% above its estimated fair value. The current Research & Development is ₹0.0 Mil. Lasa Supergenerics' overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lasa Supergenerics (NSE:LASA), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.60 is trading 74.3% above its estimated GF Value™ of ₹4.36. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹4.36 vs. price of ₹7.60 (74.3% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lasa Supergenerics Business Description

Other Exchanges 540702:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
46GF Score

Get the complete analysis for NSE:LASA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.60
Price
₹4.36
GF Value